Published in BMC Geriatr on March 17, 2010
Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease. Curr Alzheimer Res (2012) 1.48
Nutrition and neurodegeneration: epidemiological evidence and challenges for future research. Br J Clin Pharmacol (2013) 1.15
The influence of nutritional factors on the prognosis of multiple sclerosis. Nat Rev Neurol (2012) 0.97
Ginkgo biloba in Alzheimer's disease: a systematic review. Wien Med Wochenschr (2010) 0.97
Prescribing patterns in dementia: a multicentre observational study in a German network of CAM physicians. BMC Neurol (2011) 0.94
Post-stroke cognitive impairment: epidemiology, mechanisms and management. Ann Transl Med (2014) 0.91
Huperzine A for vascular dementia. Cochrane Database Syst Rev (2009) 0.90
Ginkgo biloba extract and long-term cognitive decline: a 20-year follow-up population-based study. PLoS One (2013) 0.89
Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial. Neuropsychiatr Dis Treat (2011) 0.88
Efficacy and tolerability of Ginkgo biloba extract EGb 761® in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials. Clin Interv Aging (2014) 0.85
Alzheimer's disease patient groups derived from a multivariate analysis of cognitive test outcomes in the Coalition Against Major Diseases dataset. Future Sci OA (2016) 0.85
HDL and cognition in neurodegenerative disorders. Neurobiol Dis (2014) 0.84
A Systematic Review and Meta-Analysis of Ginkgo biloba in Neuropsychiatric Disorders: From Ancient Tradition to Modern-Day Medicine. Evid Based Complement Alternat Med (2013) 0.83
EGb761 provides a protective effect against Aβ1-42 oligomer-induced cell damage and blood-brain barrier disruption in an in vitro bEnd.3 endothelial model. PLoS One (2014) 0.82
Ginkgo biloba leaf extract improves the cognitive abilities of rats with D-galactose induced dementia. J Biomed Res (2012) 0.82
A review on mitochondrial restorative mechanism of antioxidants in Alzheimer's disease and other neurological conditions. Front Pharmacol (2015) 0.82
Examining brain-cognition effects of ginkgo biloba extract: brain activation in the left temporal and left prefrontal cortex in an object working memory task. Evid Based Complement Alternat Med (2011) 0.79
An exploration of the potential mechanisms and translational potential of five medicinal plants for applications in Alzheimer's disease. Am J Neurodegener Dis (2013) 0.79
Cognitive impairment and stroke in elderly patients. Vasc Health Risk Manag (2016) 0.78
Dementia in life writing: our health care system in the words of the sufferer. Neurol Sci (2010) 0.78
The use of Ginkgo biloba in healthy elderly. Age (Dordr) (2013) 0.78
Ginkgo biloba extract individually inhibits JNK activation and induces c-Jun degradation in human chondrocytes: potential therapeutics for osteoarthritis. PLoS One (2013) 0.76
Cocoa and Dark Chocolate Polyphenols: From Biology to Clinical Applications. Front Immunol (2017) 0.76
Dementia. BMJ Clin Evid (2012) 0.75
The Relieving Effects of BrainPower Advanced, a Dietary Supplement, in Older Adults with Subjective Memory Complaints: A Randomized, Double-Blind, Placebo-Controlled Trial. Evid Based Complement Alternat Med (2016) 0.75
Identification of ginkgolide targets in brain by photoaffinity labeling. Chem Biol Drug Des (2016) 0.75
An Overview of Systematic Reviews of Ginkgo biloba Extracts for Mild Cognitive Impairment and Dementia. Front Aging Neurosci (2016) 0.75
Proteomic analysis of the low mutation rate of diploid male gametes induced by colchicine in Ginkgo biloba L. PLoS One (2013) 0.75
Efficacy and safety of Ginkgo biloba standardized extract in the treatment of vascular cognitive impairment: a randomized, double-blind, placebo-controlled clinical trial. Neuropsychiatr Dis Treat (2017) 0.75
Proteomics in Traditional Chinese Medicine with an Emphasis on Alzheimer's Disease. Evid Based Complement Alternat Med (2015) 0.75
Meta-analysis of the efficacy and safety of Ginkgo biloba extract for the treatment of dementia. J Pharm Health Care Sci (2015) 0.75
Activation of Krüppel-Like Factor 2 with Ginkgo Biloba Extract Induces eNOS Expression and Increases NO Production in Cultured Human Umbilical Endothelial Cells. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2014) 0.75
Repair and regeneration properties of Ginkgo biloba after ischemic brain injury. Neural Regen Res (2014) 0.75
Effects of Ginkgo biloba extract EGb 761® on cognitive control functions, mental activity of the prefrontal cortex and stress reactivity in elderly adults with subjective memory impairment - a randomized double-blind placebo-controlled trial. Hum Psychopharmacol (2016) 0.75
Rethinking Ginkgo biloba L.: Medicinal uses and conservation. Pharmacogn Rev (2015) 0.75
Establishing Natural Nootropics: Recent Molecular Enhancement Influenced by Natural Nootropic. Evid Based Complement Alternat Med (2016) 0.75
Dosage strength is associated with medication persistence with Ginkgo biloba drug products: a cohort study of ambulatory drug claims data in Germany. BMC Complement Altern Med (2013) 0.75
The Synergistic Beneficial Effects of Ginkgo Flavonoid and Coriolus versicolor Polysaccharide for Memory Improvements in a Mouse Model of Dementia. Evid Based Complement Alternat Med (2015) 0.75
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
A rating scale for depression. J Neurol Neurosurg Psychiatry (1960) 90.89
Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res (1983) 41.26
A new depression scale designed to be sensitive to change. Br J Psychiatry (1979) 36.40
Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology (1993) 16.92
A new rating scale for Alzheimer's disease. Am J Psychiatry (1984) 15.16
Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA (1997) 10.75
The Hawthorne Effect: a randomised, controlled trial. BMC Med Res Methodol (2007) 6.38
The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology (1997) 6.33
Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA (2008) 6.00
Assessing quality of life in older adults with cognitive impairment. Psychosom Med (2002) 4.52
Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Ann Intern Med (2008) 4.03
Ginkgo biloba for mild to moderate dementia in a community setting: a pragmatic, randomised, parallel-group, double-blind, placebo-controlled trial. Int J Geriatr Psychiatry (2008) 3.03
The Alzheimer's disease activities of daily living international scale (ADL-IS). Int Psychogeriatr (2001) 2.84
A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAMA (1997) 2.80
A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline. Neurology (2008) 1.91
Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology. Health Technol Assess (2005) 1.83
Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis. Clin Interv Aging (2008) 1.72
Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials. PLoS Med (2007) 1.68
Systematic review of measures of clinical significance employed in randomized controlled trials of drugs for dementia. J Am Geriatr Soc (2009) 1.54
Measurement of quality-of-life changes in patients with Alzheimer's disease. Clin Ther (1989) 1.50
Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev (2009) 1.41
A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type. Curr Alzheimer Res (2005) 1.39
Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. Curr Drug Targets (2000) 1.38
Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type. J Psychiatr Res (1998) 1.21
Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiatry (1996) 1.17
Checklist for the qualitative evaluation of clinical studies with particular focus on external validity and model validity. BMC Med Res Methodol (2006) 1.12
Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial. Pharmacopsychiatry (2003) 1.07
Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial. J Clin Epidemiol (2003) 1.05
The Gottfries-Bråne-Steen scale: validity, reliability and application in anti-dementia drug trials. Dement Geriatr Cogn Disord (2001) 1.05
Ginkgo biloba extract EGb 761(R), donepezil or both combined in the treatment of Alzheimer's disease with neuropsychiatric features: a randomised, double-blind, exploratory trial. Aging Ment Health (2009) 1.03
Ginkgo biloba special extract in dementia with neuropsychiatric features. A randomised, placebo-controlled, double-blind clinical trial. Arzneimittelforschung (2007) 1.03
Stabilization of mitochondrial membrane potential and improvement of neuronal energy metabolism by Ginkgo biloba extract EGb 761. Ann N Y Acad Sci (2005) 1.00
A 26-week analysis of a double-blind, placebo-controlled trial of the ginkgo biloba extract EGb 761 in dementia. Dement Geriatr Cogn Disord (2000) 0.99
Damaged neuronal energy metabolism and behavior are improved by Ginkgo biloba extract (EGb 761). J Neural Transm (Vienna) (1999) 0.94
Potential interaction of Ginkgo biloba leaf with antiplatelet or anticoagulant drugs: what is the evidence? Mol Nutr Food Res (2008) 0.89
The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: new results of a randomized clinical trial. J Am Geriatr Soc (2000) 0.88
Factor structure and scoring of the SKT test battery. J Clin Psychol (1993) 0.88
[External validity of clinical trials for treatment of dementia with ginkgo biloba extracts]. Z Gerontol Geriatr (2008) 0.87
Effects of Ginkgo biloba extract EGb 761 on neuropsychiatric symptoms of dementia: findings from a randomised controlled trial. Wien Med Wochenschr (2007) 0.87
Development and validation of the geriatric evaluation by relatives rating instrument (GERRI). Psychol Rep (1983) 0.86
Ginkgo biloba extract and preventing Alzheimer disease. JAMA (2008) 0.84
An example for an underpowered study: a comment on Ginkgo biloba for mild to moderate dementia in a community setting by McCarney et al. Int J Geriatr Psychiatry (2009) 0.78
Identification of adverse drug reactions by evaluation of a prescription database, demonstrated for "risk of bleeding". Methods Inf Med (2005) 0.78
A comment on Ginkgo biloba for mild to moderate dementia in a community setting by McCarney et al. Int J Geriatr Psychiatry (2009) 0.77
Acupuncture in patients with chronic low back pain: a randomized controlled trial. Arch Intern Med (2006) 4.51
The impact of patient expectations on outcomes in four randomized controlled trials of acupuncture in patients with chronic pain. Pain (2007) 4.18
Acupuncture for patients with migraine: a randomized controlled trial. JAMA (2005) 3.70
Obesity prevalence from a European perspective: a systematic review. BMC Public Health (2008) 3.67
Safety of acupuncture: results of a prospective observational study with 229,230 patients and introduction of a medical information and consent form. Forsch Komplementmed (2009) 3.35
Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil (2008) 3.13
Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behavior. Neurology (2010) 3.08
Acupuncture in patients with tension-type headache: randomised controlled trial. BMJ (2005) 2.47
Pragmatic randomized trial evaluating the clinical and economic effectiveness of acupuncture for chronic low back pain. Am J Epidemiol (2006) 2.31
Acupuncture in patients with osteoarthritis of the knee or hip: a randomized, controlled trial with an additional nonrandomized arm. Arthritis Rheum (2006) 2.20
German recommendations on health economic evaluation: third and updated version of the Hanover Consensus. Value Health (2008) 2.20
Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer (2008) 2.16
The costs of atrial fibrillation in patients with cardiovascular comorbidities--a longitudinal analysis of German health insurance data. Europace (2011) 2.11
Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours. Endocr Relat Cancer (2008) 2.08
Interaction of serotonin reuptake inhibitors with tamoxifen. BMJ (2010) 2.06
Long-term effectiveness of interventions promoting physical activity: a systematic review. Prev Med (2008) 1.94
Acupuncture for migraine prophylaxis: a randomized controlled trial. CMAJ (2012) 1.87
An update on regional variation in cardiovascular mortality within Europe. Eur Heart J (2008) 1.83
Acupuncture in patients with seasonal allergic rhinitis: a randomized trial. Ann Intern Med (2013) 1.76
The in vitro evidence for an effect of high homeopathic potencies--a systematic review of the literature. Complement Ther Med (2007) 1.74
Priapism associated with antipsychotics: role of alpha1 adrenoceptor affinity. J Clin Psychopharmacol (2010) 1.66
The acupuncture randomised trial (ART) for tension-type headache--details of the treatment. Acupunct Med (2005) 1.62
Prospective follow-up data from the ProGERD study suggest that GERD is not a categorial disease. Am J Gastroenterol (2006) 1.62
How objective are systematic reviews? Differences between reviews on complementary medicine. J R Soc Med (2003) 1.62
Regional Differences in the Prevalence of Cardiovascular Disease. Dtsch Arztebl Int (2016) 1.61
Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry. Clin Res Cardiol (2011) 1.58
Health-economic burden of obesity in Europe. Eur J Epidemiol (2008) 1.54
Remedies containing Asteraceae extracts: a prospective observational study of prescribing patterns and adverse drug reactions in German primary care. Drug Saf (2009) 1.53
Educational intervention to improve physician reporting of adverse drug reactions (ADRs) in a primary care setting in complementary and alternative medicine. BMC Public Health (2009) 1.51
Methods for determining cost-benefit ratios for pharmaceuticals in Germany. Eur J Health Econ (2007) 1.49
How unusual are the contents of paraphilias? Paraphilia-associated sexual arousal patterns in a community-based sample of men. J Sex Med (2011) 1.46
Neuroendocrine tumors of midgut and hindgut origin: tumor-node-metastasis classification determines clinical outcome. Cancer (2011) 1.46
Acupuncture for patients with chronic neck pain. Pain (2006) 1.41
Does potentized HgCl2 (Mercurius corrosivus) affect the activity of diastase and alpha-amylase? J Altern Complement Med (2006) 1.40
Regional trends in cerebrovascular mortality in Germany after unification (1990-1999). Cerebrovasc Dis (2003) 1.39
Does pet ownership in infancy lead to asthma or allergy at school age? Pooled analysis of individual participant data from 11 European birth cohorts. PLoS One (2012) 1.39
Acupuncture and moxibustion in the treatment of ulcerative colitis: a randomized controlled study. Scand J Gastroenterol (2006) 1.38
Mild therapeutic hypothermia after cardiac arrest - a nationwide survey on the implementation of the ILCOR guidelines in German intensive care units. Resuscitation (2006) 1.34
Out-of-hospital delays in patients with acute stroke. Ann Emerg Med (2004) 1.32
Outcome and costs of homoeopathic and conventional treatment strategies: a comparative cohort study in patients with chronic disorders. Complement Ther Med (2005) 1.31
Use and safety of anthroposophic medications in chronic disease: a 2-year prospective analysis. Drug Saf (2006) 1.31
Homeopathic medical practice: long-term results of a cohort study with 3981 patients. BMC Public Health (2005) 1.29
Barriers to routine risk-score use for healthy primary care patients: survey and qualitative study. Arch Intern Med (2010) 1.20
Use of complementary and alternative medicine in Germany - a survey of patients with inflammatory bowel disease. BMC Complement Altern Med (2006) 1.19
Plasma resistin levels and risk of myocardial infarction and ischemic stroke. J Clin Endocrinol Metab (2008) 1.16
Anthroposophic therapy for chronic depression: a four-year prospective cohort study. BMC Psychiatry (2006) 1.13
Health costs in anthroposophic therapy users: a two-year prospective cohort study. BMC Health Serv Res (2006) 1.12
Acupuncture in patients with allergic rhinitis: a pragmatic randomized trial. Ann Allergy Asthma Immunol (2008) 1.11
The effect of a community-based coronary risk reduction: the Rockford CHIP. Prev Med (2007) 1.10
Knowledge of risk factors, and warning signs of stroke: a systematic review from a gender perspective. Int J Stroke (2011) 1.09
Cataract surgery and the development or progression of age-related macular degeneration: a systematic review. Surv Ophthalmol (2008) 1.09
Review Article: Increasing physical activity with point-of-choice prompts--a systematic review. Scand J Public Health (2010) 1.09
Association between behavior-dependent cardiovascular risk factors and asymptomatic carotid atherosclerosis in a general population. Stroke (2002) 1.08
The costs of care in atrial fibrillation and the effect of treatment modalities in Germany. Value Health (2008) 1.08
Effectiveness of nonpharmacological secondary prevention of coronary heart disease. Eur J Cardiovasc Prev Rehabil (2010) 1.06
Quality assessment of physical research in homeopathy. J Altern Complement Med (2003) 1.06
Patient counselling on the risk of infertility and its impact on childhood cancer survivors: results from a national survey. J Psychosoc Oncol (2011) 1.06
Comparative effectiveness of a complex Ayurvedic treatment and conventional standard care in osteoarthritis of the knee--study protocol for a randomized controlled trial. Trials (2013) 1.05
The impact of atrial fibrillation on the cost of stroke: the berlin acute stroke study. Value Health (2007) 1.05
Acupuncture in patients with dysmenorrhea: a randomized study on clinical effectiveness and cost-effectiveness in usual care. Am J Obstet Gynecol (2008) 1.03
Patient characteristics and variation in treatment outcomes: which patients benefit most from acupuncture for chronic pain? Clin J Pain (2011) 1.03
Eurythmy therapy in chronic disease: a four-year prospective cohort study. BMC Public Health (2007) 1.03
Rhythmical massage therapy in chronic disease: a 4-year prospective cohort study. J Altern Complement Med (2007) 1.02
Study of perceptions of the extent to which guideline recommendations are binding: a survey of commonly used terminology. Dtsch Arztebl Int (2013) 1.02
Patenting of university and non-university public research organisations in Germany: evidence from patent applications for medical research results. PLoS One (2010) 1.01
Impact of pain on health-related quality of life in patients with inflammatory bowel disease. World J Gastroenterol (2010) 1.01
Should systematic reviews include non-randomized and uncontrolled studies? The case of acupuncture for chronic headache. J Clin Epidemiol (2002) 1.00
Treatment of the adverse effects from acupuncture and their economic impact: a prospective study in 73,406 patients with low back or neck pain. Eur J Pain (2010) 0.99
Homeopathic treatment of elderly patients--a prospective observational study with follow-up over a two year period. BMC Geriatr (2010) 0.99
Association of body mass index with heartburn, regurgitation and esophagitis: results of the Progression of Gastroesophageal Reflux Disease study. J Gastroenterol Hepatol (2007) 0.99
Cost-effectiveness of acupuncture in women and men with allergic rhinitis: a randomized controlled study in usual care. Am J Epidemiol (2009) 0.98
Alcohol consumption, genetic variants in alcohol deydrogenases, and risk of cardiovascular diseases: a prospective study and meta-analysis. PLoS One (2012) 0.98
Is patient self-report an adequate tool for monitoring cardiovascular conditions in patients with hypercholesterolemia? J Public Health (Oxf) (2010) 0.97
Quality of life and cost-effectiveness of acupuncture treatment in patients with osteoarthritis pain. Eur J Health Econ (2007) 0.97
History of respiratory infections in the first 12 yr among children from a birth cohort. Pediatr Allergy Immunol (2007) 0.97
Knowledge about risk factors for stroke: a population-based survey with 28,090 participants. Stroke (2006) 0.96
Appropriateness of colonoscopy in the era of colorectal cancer screening: a prospective, multicenter study in a private-practice setting (Berlin Colonoscopy Project 1, BECOP 1). Dis Colon Rectum (2007) 0.96
Qigong and exercise therapy for elderly patients with chronic neck pain (QIBANE): a randomized controlled study. J Pain (2009) 0.96
Anthroposophic medical therapy in chronic disease: a four-year prospective cohort study. BMC Complement Altern Med (2007) 0.96
Referral practices in patients suffering from non-malignant chronic pain. Eur J Pain (2009) 0.95
Economic and human costs of restless legs syndrome. Pharmacoeconomics (2009) 0.95
Anticoagulation treatment for the reduction of stroke in atrial fibrillation: a cohort study to examine the gap between guidelines and routine medical practice. J Thromb Thrombolysis (2007) 0.95
Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry). Am J Cardiol (2009) 0.93